Tumor cells undergo significant GPL remodeling and phospholipase A2 and lysophosphatidylcholine acyltransferase (LPCAT) are the key enzymes of this process, which can be used as tumor markers and potential targets for therapy 52. Here, IL31RA is linked to neoplasm.